Opportunity ID: 334917

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-DK-21-018
Funding Opportunity Title: Pilot and Feasibility Studies to Improve Technology Adoption and Reduce Health Disparities in Type 1 Diabetes Mellitus (R01 Clinical Trial Required)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Food and Nutrition
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.847 — Diabetes, Digestive, and Kidney Diseases Extramural Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jul 28, 2021
Last Updated Date: Jul 28, 2021
Original Closing Date for Applications: Mar 03, 2022
Current Closing Date for Applications: Mar 03, 2022
Archive Date: Apr 08, 2022
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Independent school districts
Native American tribal organizations (other than Federally recognized tribal governments)
Public and State controlled institutions of higher education
For profit organizations other than small businesses
Native American tribal governments (Federally recognized)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Special district governments
Private institutions of higher education
County governments
City or township governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
State governments
Small businesses
Public housing authorities/Indian housing authorities
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this Funding Opportunity Announcement (FOA) is to support pilot and feasibility trials of interventions designed to improve technology adoption in individuals from underrepresented backgrounds with type 1 diabetes mellitus (T1D). Through successful execution, these pilot and feasibility trials should provide feasibility data for larger, pragmatic trials with the overarching goal of reducing health disparity in T1D through improving technology usage in individuals from minority racial and ethnic backgrounds.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-21-018.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
grantsinfo@nih.gov
Email:grantsinfo@nih.gov

Version History

Version Modification Description Updated Date

Folder 334917 Full Announcement-RFA-DK-21-018 -> RFA-DK-21-018-Full-Announcement.pdf

Packages

Agency Contact Information: NIH OER Webmaster
grantsinfo@nih.gov
Email: grantsinfo@nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-G Use for due dates on or after January 25, 2022 PKG00269867 Feb 03, 2022 Mar 03, 2022 View
FORMS-F Use for due dates on or before January 24, 2022 PKG00268327 Feb 03, 2022 Jan 24, 2022 View

Package 1

Mandatory forms

334917 RR_SF424_5_0-5.0.pdf

334917 PHS398_CoverPageSupplement_5_0-5.0.pdf

334917 RR_OtherProjectInfo_1_4-1.4.pdf

334917 PerformanceSite_4_0-4.0.pdf

334917 RR_KeyPersonExpanded_4_0-4.0.pdf

334917 PHS398_ResearchPlan_4_0-4.0.pdf

334917 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

334917 RR_Budget_3_0-3.0.pdf

334917 RR_SubawardBudget30_3_0-3.0.pdf

334917 PHS398_ModularBudget_1_2-1.2.pdf

334917 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 2

Mandatory forms

334917 RR_SF424_2_0-2.0.pdf

334917 PHS398_CoverPageSupplement_5_0-5.0.pdf

334917 RR_OtherProjectInfo_1_4-1.4.pdf

334917 PerformanceSite_2_0-2.0.pdf

334917 RR_KeyPersonExpanded_2_0-2.0.pdf

334917 PHS398_ResearchPlan_4_0-4.0.pdf

334917 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

334917 RR_Budget_1_4-1.4.pdf

334917 RR_SubawardBudget30_1_4-1.4.pdf

334917 PHS398_ModularBudget_1_2-1.2.pdf

334917 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-11T15:33:19-05:00

Share This Post, Choose Your Platform!

About the Author: